Development of a novel small non-antibody protein scaffold as a therapy to reduce the SARS-Cov2 viral load
- Funded by British Society for Antimicrobial Chemotherapy (BSAC)
- Total publications:0 publications
Grant number: BSAC-COVID-43
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$31,250Funder
British Society for Antimicrobial Chemotherapy (BSAC)Principal Investigator
Rajika PereraResearch Location
United States of AmericaLead Research Institution
CEO, Poseidon LLC, Pasadena, CaliforniaResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable